Using the Gate Control Theory of Pain to Decrease Pain During Trigger Finger Corticosteroid Injections

NCT ID: NCT06401473

Last Updated: 2024-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-11

Study Completion Date

2024-04-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to investigate a new noninvasive technique that patients may use to help reduce the pain that they experience during cortisone injections for trigger fingers. It will also help provide information that may help support the gate control theory of pain as a framework for understanding and managing acute pain.The main questions it aims to answer are:

Can a physical stimulus near the site of cortisone injection reduce the pain experienced by the patient during the injection? Does the physical stimulation or the cognitive distraction contribute more to pain relief?

Researchers will compare a physical stimulus near the injection site to a placebo (a similar task that theoretically should not reduce the experience of pain) to see if physical stimuli work to improve pain during injections.

Participants will:

Estimate how much pain they expect to experience during a cortisone injection Receive a cortisone injection for a trigger finger while performing one of three possible actions (control, placebo task, or the investigated physical stimulus near the injection site) Express how much pain they actually experienced during the injection

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trigger Finger Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Random assignment into one of three parallel groups: control, distraction, or experimental
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Patients remained blinded to their assigned intervention until after all study procedures were complete.

Injecting provider was technically blinded but was functionally unblinded at the time of the injection itself due to the visible and audible differences between each group throughout the course of the injection.

Outcome assessor was blinded while instructing patients how to denote their pain level after the procedure, but was unblinded at the time of the injection. No input was given by the outcome assessor after they were unblinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Patients received no intervention during cortisone injection.

Group Type NO_INTERVENTION

No interventions assigned to this group

Distraction

Patients were instructed on a sham motor distraction task on the contralateral upper limb and performed this task during cortisone injection.

Group Type SHAM_COMPARATOR

Motor Distraction Task

Intervention Type BEHAVIORAL

Patients scratch the skin of the shoulder/neck contralateral to the injection site

Experimental

Patients were instructed on the experimental task, involving scratching the upper limb ipsilateral to the site of the injection, and they performed this task during cortisone injection.

Group Type EXPERIMENTAL

Ipsilateral Scratch Task

Intervention Type BEHAVIORAL

Patients scratch the skin within the relevant cervical dermatome, ipsilateral to the injection site

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ipsilateral Scratch Task

Patients scratch the skin within the relevant cervical dermatome, ipsilateral to the injection site

Intervention Type BEHAVIORAL

Motor Distraction Task

Patients scratch the skin of the shoulder/neck contralateral to the injection site

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Are at least 18 years of age.
* Have been diagnosed with one or more "trigger fingers" of the index, middle, ring, or small fingers.
* Have decided to try a cortisone injection for one or more trigger fingers today as advised by your physician.
* Are able to read and understand these study procedures.

Exclusion Criteria

* Are severely visually impaired.
* Have a history of spinal cord injury.
* Have taken opioid pain medications in the last 28 days.
* Are currently pregnant.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Grand Canyon University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aidan Crislip

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aidan Crislip, BS

Role: PRINCIPAL_INVESTIGATOR

Grand Canyon University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

OrthoArizona

Gilbert, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-2023-5842

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Carpal Tunnel Release Efficacy Trial
NCT06934187 NOT_YET_RECRUITING NA